Risk of subsequent vitiligo in transplantation recipients with comorbid graft versus host disease: A nationwide population-based cohort study
Published: 20 December 2022| Version 1 | DOI: 10.17632/56xg8tkwsr.1
Contributors:
, , , Jin-hyung Jung, , , Description
Supplemental Figure 1. Flowchart of included patients Supplemental Table 1. Characteristics of the study population Supplemental Table 2. Subgroup analysis on the risk of vitiligo by HSCT graft type, stem cell source, and comorbid GVHD Supplemental Table 3. Risks and incidence rates of vitiligo in patients with transplantation according to a health check-up database.
Files
Institutions
Catholic University of Korea School of Medicine, Catholic University of Korea
Categories
Hematopoietic Stem Cell Transplantation, Organ Transplantation, Vitiligo, Graft-versus-Host Disease
Funding
National Research Foundation of Korea
2021R1I1A1A01045146